Related Experiment Video
Updated: Feb 6, 2026

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
Published on: September 23, 2014
Biomarker prediction for membranous nephropathy prognosis by microarray analysis
Guangyu Zhou1, Guangda Xin1, Wenlong Zhang2
1Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, China.
Aim:
This study aimed to explore biomarkers for membranous nephropathy (MN) diagnosis and to provide novel insights into the pathogenesis of this disease.
Methods:
A microarray data set, GSE73953, was used, which contained 15 immunoglobulin A nephropathy (IgAN) samples, 8 MN samples and 2 healthy controls. Pretreatments were performed for the raw data, and then, the differentially expressed genes (DEG) were screened out using the limma package. The function and pathways of these genes were demonstrated through enrichment analysis. Protein-protein interaction (PPI) network analysis was performed to uncover interactions of DEG from the protein level. MN-related genes were further selected, integrating the Comparative Toxicogenomics Database (CTD).
Results:
In total, 446 and 231 DEG were identified in the comparisons of MN versus control and MN versus IgAN, respectively. JUN, NFKB1, TGFB1 and PPBP were the predominant DEG, and the latter two were especially differentially expressed between the MN and IgAN groups. UBL4A and EIF4G1 were the two most important DEG for MN because they were downregulated compared with both control and IgAN groups. The above-mentioned genes were highlighted in the PPI networks and mainly enriched the ribosome- and platelet-related function/pathways.
Conclusion:
Several potential biomarkers were identified in MN, and some of them could well distinguish the MN from IgAN. Disruption of ribosome- and platelet-related function or pathways might contribute to MN progression. EIF4F and UBL4A might be two novel biomarkers for MN prognosis. Nevertheless, more experimental validations are needed.
Insights
This study identified potential biomarkers for membranous nephropathy (MN) diagnosis and progression. Ribosome and platelet pathway disruptions may contribute to MN, with EIF4F and UBL4A showing promise as novel biomarkers.
Area of Science:
- Nephrology
- Genomics
- Molecular Biology
Background:
- Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
- Accurate diagnosis and understanding the pathogenesis of MN are crucial for effective treatment.
- Current diagnostic methods may lack specificity, necessitating the search for novel biomarkers.
Purpose of the Study:
- To identify potential diagnostic and prognostic biomarkers for membranous nephropathy (MN).
- To gain insights into the molecular mechanisms and pathways involved in MN pathogenesis.
- To differentiate MN from immunoglobulin A nephropathy (IgAN) using gene expression profiles.
Main Methods:
- Utilized microarray data (GSE73953) comparing MN, IgAN, and healthy control samples.
- Applied differential gene expression analysis (limma package) to identify key genes.
- Performed enrichment analysis and protein-protein interaction (PPI) network analysis.
- Integrated the Comparative Toxicogenomics Database (CTD) to select MN-related genes.
Main Results:
- Identified 446 differentially expressed genes (DEG) between MN and controls, and 231 DEG between MN and IgAN.
- Highlighted JUN, NFKB1, TGFB1, and PPBP as predominant DEG; TGFB1 and PPBP distinguished MN from IgAN.
- Found UBL4A and EIF4G1 to be significantly downregulated in MN compared to both control and IgAN groups.
- DEG were enriched in ribosome and platelet-related functions/pathways.
Conclusions:
- Identified several potential biomarkers for MN diagnosis, with some differentiating MN from IgAN.
- Disruption of ribosome and platelet-related pathways may play a role in MN progression.
- EIF4F and UBL4A are proposed as novel potential biomarkers for MN prognosis, requiring further experimental validation.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Predicting Molecular Geometry
DNA Microarrays
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Predicting Reaction Outcomes